Radiopaque embolic particles

A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ abl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BOYD DANIEL, ABRAHAM ROBERT J, KEHOE SHARON
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BOYD DANIEL
ABRAHAM ROBERT J
KEHOE SHARON
description A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ613872A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ613872A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ613872A3</originalsourceid><addsrcrecordid>eNrjZJAJSkzJzC9ILCxNVUjNTcrPyUxWKEgsKslMzkkt5mFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8X5RZobGFuZGjsYEFQAA7G4i7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Radiopaque embolic particles</title><source>esp@cenet</source><creator>BOYD DANIEL ; ABRAHAM ROBERT J ; KEHOE SHARON</creator><creatorcontrib>BOYD DANIEL ; ABRAHAM ROBERT J ; KEHOE SHARON</creatorcontrib><description>A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage.</description><language>eng</language><subject>CHEMISTRY ; COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F ; COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM ; COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS ; COMPOUNDS THEREOF ; HUMAN NECESSITIES ; HYGIENE ; INORGANIC CHEMISTRY ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NON-METALLIC ELEMENTS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160129&amp;DB=EPODOC&amp;CC=NZ&amp;NR=613872A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160129&amp;DB=EPODOC&amp;CC=NZ&amp;NR=613872A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BOYD DANIEL</creatorcontrib><creatorcontrib>ABRAHAM ROBERT J</creatorcontrib><creatorcontrib>KEHOE SHARON</creatorcontrib><title>Radiopaque embolic particles</title><description>A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage.</description><subject>CHEMISTRY</subject><subject>COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F</subject><subject>COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM</subject><subject>COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS</subject><subject>COMPOUNDS THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INORGANIC CHEMISTRY</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NON-METALLIC ELEMENTS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJSkzJzC9ILCxNVUjNTcrPyUxWKEgsKslMzkkt5mFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8X5RZobGFuZGjsYEFQAA7G4i7g</recordid><startdate>20160129</startdate><enddate>20160129</enddate><creator>BOYD DANIEL</creator><creator>ABRAHAM ROBERT J</creator><creator>KEHOE SHARON</creator><scope>EVB</scope></search><sort><creationdate>20160129</creationdate><title>Radiopaque embolic particles</title><author>BOYD DANIEL ; ABRAHAM ROBERT J ; KEHOE SHARON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ613872A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F</topic><topic>COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM</topic><topic>COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS</topic><topic>COMPOUNDS THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INORGANIC CHEMISTRY</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NON-METALLIC ELEMENTS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BOYD DANIEL</creatorcontrib><creatorcontrib>ABRAHAM ROBERT J</creatorcontrib><creatorcontrib>KEHOE SHARON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BOYD DANIEL</au><au>ABRAHAM ROBERT J</au><au>KEHOE SHARON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Radiopaque embolic particles</title><date>2016-01-29</date><risdate>2016</risdate><abstract>A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ613872A
source esp@cenet
subjects CHEMISTRY
COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F
COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM
COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS
COMPOUNDS THEREOF
HUMAN NECESSITIES
HYGIENE
INORGANIC CHEMISTRY
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NON-METALLIC ELEMENTS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Radiopaque embolic particles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A44%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BOYD%20DANIEL&rft.date=2016-01-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ613872A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true